Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 11, 2019

View Archived Issues

New antibody against F glycoprotein prevents membrane fusion and viral entry in NiV, HeV infections

Novel dietary-induced mouse model of NASH with severe fibrosis

Celldex reports results from ongoing phase I study of CDX-1140

Enrollment ongoing in phase III study of TV P2-VP8 vaccine

Pfizer initiates phase III study of PF-06741086

Phase IIb ATLAS study of etokimab fails to meet the primary endpoint

Update given for the phase III JAVELIN gastric 100 trial

UMC Utrecht Holding discloses thombolytic fusion proteins

IL-38 protein compositions described by Reyoung Suzhou Biology Science & Technology

FORMA Therapeutics discovers histone deacetylase 11 inhibitors

Medshine Discovery patents Rho kinase inhibitors

Roche and Genentech identify new RIP-1 inhibitors

Simpler recipe makes better cocktail for iPSCs

Exosomes help brain metastases along

Novel AVV-based vector therapy for the treatment of AD

New DREADD tools for noninvasive manipulation and visualization of neuronal circuits in animals

Zelluna Immunotherapy presents novel compound, ZI-H04, as cancer immunotherapeutic

Glecaprevir/pibrentasvir investigated in young children with chronic HCV infection

Now, Sleeping Beauty is the fairest of them all

NKTR-358 safe and well tolerated in first-in-human study

SUNFISH study of risdiplam in type 2 and 3 SMA meets primary endpoint

FDA approves Reblozyl for anemia in beta thalassemia requiring regular RBC transfusions

First-in-human comparison of LY-2775240 and apremilast in healthy volunteers

New phase IIa study investigates use of MTPS-9579A in asthma

Lyvgen initiates first-in-human study of LVGN-6051 in advanced or metastatic malignancy

Roche announces discontinuation of RG-6206 development in DMD

Oncogene-linked prodrug strategy for selective KEAP1 mutant NSCLC cytotoxicity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.